Braden Michael Leonard, 10% Owner at Reneo Pharmaceuticals, Inc. (RPHM), bought 98,346 shares at $1.50 ($145K) on 2024-09-25, disclosed to the SEC on 2024-09-26.
Open-market purchase of $145k RPHM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.41 | 29,600 | $42K | 28.8% |
| 2 | $1.50 | 68,746 | $103K | 71.2% |
| Total | $1.47 avg | 98,346 | $145K | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |